Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    2342578 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
Conditions: Solid Tumors;   Lymphoma
Intervention: Drug: Imetelstat

Indicates status has not been verified in more than two years